Health Care • Hospital/Nursing Management
$24.68 ▲ +0.62
(+2.58%)
MKT CAP: $1.66B • VOL: 712.9K
52W L $17 52W H $26
ROARABLE / RQD
B- • 70/100
PIOTROSKI
7 / 9
HCSG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.84B | $1.72B | $1.67B |
| YoY Revenue Growth % | +7.1% | +2.7% | — |
| Gross Profit | $239.4M | $228.1M | — |
| Gross Margin % | 13.0% | 13.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $59.1M | $39.5M | $38.4M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $145.0M | $30.8M | $43.5M |
| Capital Expenditures (CapEx) | $5.8M | $6.3M | — |
| Free Cash Flow (FCF) | $139.2M | $24.5M | $43.5M |
| FCF Margin % | 7.6% | 1.4% | 2.6% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $125.2M | $56.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $510.2M | $499.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HCSG.